Method of improvement of insulin sensitivity in obese patients
US10888536B1 · kind B1 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 28, 2019 |
| Grant date | Jan 12, 2021 |
| Priority date | — |
| Expiry date | Aug 28, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for improving insulin sensitivity in obesity-induced metabolic syndrome by administering propanamide to a subject in need thereof the increase of ATP synthesis, decreasing inflammation, reducing accumulation of visceral fat and improving hyperglycemia and hyperinsulinemia. Propanamide can be orally administered to the subject. Propanamide can be administered to the subject in a dosage of 11.56-15.38 mg/kg/day. Propanamide can be administered to the subject postprandially.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.